Common use of SUCCESSOR LIABILITY Clause in Contracts

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Arc proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Xxx wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Arc must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior VITAS proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior VITAS wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior VITAS must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.. Vitas Corporate Integrity Agreement

SUCCESSOR LIABILITY. In the event thatIf, after the Effective Date, Indivior Advanced Bionics proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIAengage in any of the Covered Functions; or (b) purchases or establishes a new business, business unit or location related relating to or engaged that will engage in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such location and any new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Advanced Bionics shall give notice notify OIG, in writing, of such sale or purchase to OIG within 30 days following the closing of the transaction. Iftransaction and shall notify OIG, in advance writing, within 30 days of a proposed sale establishing such new business, business unit or a proposed purchase, Indivior location. If Advanced Bionics wishes to obtain a determination by OIG that the a proposed purchaser purchase or the proposed acquisition will not be subject to the requirements of the CIACIA requirements, Indivior Advanced Bionics must notify OIG in writing at least 30 days in advance of the proposed sale or purchase at least 30 days in advancepurchase. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior PCMC proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior PCMC wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior PCMC must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Indivior WCH proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior WCH wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior WCH must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior RMS proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior RMS shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior RMS wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior RMS must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior VITAS proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior VITAS wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior VITAS must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief VITAS Corporate Integrity Agreement description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior MB2 Dental proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior MB2 Dental wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIAXXX, Indivior XX0 Dental must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior ION proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior XXX wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior ION must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Jazz proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIAengaged in any of the Covered Functions; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Jazz shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Jazz wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Jazz must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Arthrex proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Arthrex shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Arthrex wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Arthrex must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior CSI proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior CSI wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior CSI must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Taro proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Pricing and Contracting Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Taro shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Xxxx wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Taro must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description Corporate Integrity Agreement Taro Pharmaceuticals USA, Inc. of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior LCCA proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchasepurchase as described above, Indivior LCCA wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior LCCA must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Indivior ACell proposes to to: (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases purchase or establishes establish a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any such business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new ACell, Inc. Corporate Integrity Agreement business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior ACell shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior XXxxx wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior ACell must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior FCVN proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior FCVN wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior FCVN must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ​ In the event that, after the Effective Date, Indivior Merit proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Merit shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. ​ If, in advance of a proposed sale or a proposed purchase, Indivior Merit wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Merit must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.. ​

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Indivior Avanir proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Avanir shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Xxxxxx wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Avanir must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief Avanir Pharmaceuticals, Inc. Corporate Integrity Agreement description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior PGS proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior PGS wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior PGS must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Primex proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Primex wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Primex must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Vibra proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchasepurchase as described above, Indivior Xxxxx wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Vibra must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Indivior Mercy proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Mercy wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Mercy must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior CVS Health proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior CVS Health wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior CVS Health must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Indivior Sanofi proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Sanofi shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. Sanofi Corporate Integrity Agreement If, in advance of a proposed sale or a proposed purchase, Indivior Sanofi wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Sanofi must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Vanguard proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Vanguard wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Vanguard must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Novartis proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Novartis shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. Novartis Corporate Integrity Agreement If, in advance of a proposed sale or a proposed purchase, Indivior Novartis wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Novartis must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Xxxxxx proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Xxxxxx wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Xxxxxx must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Indivior RMS proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior RMS shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior RMS wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior RMS must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Indivior HealthNet proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior HealthNet wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior HealthNet must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Indivior Spring Gate proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Spring Gate wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Spring Gate must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Merit proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Merit shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Merit wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Merit must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description Merit Medical Systems, Inc. October 8, 2020 of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that‌ If, after the Effective Date, Indivior Biotronik proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIAengage in any of the Covered Functions; or (b) purchases or establishes a new business, business unit or location related relating to or engaged that will engage in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such location and any new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Biotronik shall give notice notify OIG, in writing, of such sale or purchase to OIG within 30 days following the closing of the transaction. Iftransaction and shall notify OIG, in advance writing, within 30 days of a proposed sale establishing such new business, business unit or a proposed purchase, Indivior location. If Biotronik wishes to obtain a determination by OIG that the a proposed purchaser purchase or the proposed acquisition will not be subject to the requirements of the CIACIA requirements, Indivior Biotronik must notify OIG in writing at least 30 days in advance of the proposed sale or purchase at least 30 days in advancepurchase. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Indivior USWM proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior USWM shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior USWM wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior USWM must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior TGS proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior TGS wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior TGS must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Indivior ABC proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior ABC shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchasepurchase as described above, Indivior ABC wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior ABC must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior SUN proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior SUN shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior SUN wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior SUN must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.. SUN Corporate Integrity Agreement

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Medstar proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Medstar wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Medstar must notify OIG in writing of the Corporate Integrity Agreement - Medstar proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Sutter proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) that are subject relating to this CIAthe provision of Covered Functions; or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to or engaged in any the provision of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Sutter shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Sutter wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Sutter must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.. Xxxxxx Health Corporate Integrity Agreement

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Preferred Imaging proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Preferred Imaging wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Preferred Imaging must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.. Preferred Imaging Centers, LLC Corporate Integrity Agreement

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Xxxxxx Valley proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Xxxxxx Valley wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Xxxxxx Valley must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Essilor proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Essilor shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Xxxxxxx wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Essilor must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Indivior Amgen proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Amgen shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Amgen wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Amgen must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Mallinckrodt proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Mallinckrodt shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Mallinckrodt wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Mallinckrodt must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior AmeriCare proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior AmeriCare wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior AmeriCare must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌‌‌ In the event that, after the Effective Date, Indivior a GIS Party proposes to (a) sell any or all of its their business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior a GIS Party wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior the GIS Party must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Sandoz proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Pricing and Contracting Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Sandoz shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Sandoz wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Sandoz must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior Aegerion proposes to to: (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) that are engaged in any Covered Functions or subject to this the CIA; , or (b) purchases purchase or establishes establish a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit unit, or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Aegerion wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Aegerion must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, unit or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective proposed purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Indivior Respironics proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Respironics shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Respironics wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Respironics must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Indivior Astellas proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Astellas shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Astellas wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Astellas must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief Corporate Integrity Agreement Astellas Pharma US, Inc. description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Indivior SDNA proposes to (a) sell any or all of its business, business units units, or locations (whether through a sale of assets, sale of stock stock, or other type of transaction) relating to the furnishing of items or services that are subject to this CIA; may be reimbursed by a Federal health care program, or (b) purchases purchase or establishes establish a new business, business unit unit, or location related relating to the furnishing of items or engaged in any of the Covered Functionsservices that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit unit, or location. Any such location and any new business, business unit unit, or location (and all Covered Persons at each new business, business unit unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior SDNA wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior SDNA must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Indivior Insys proposes to (a) sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock or other type of transaction) that are subject to this CIA; or (b) purchases or establishes a new business, business unit or location related to or engaged in any of the Covered Functions, the CIA shall be binding on the purchaser of any business, business unit or location. Any such new business, business unit or location (and all Covered Persons at each new business, business unit or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Indivior Insys shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Indivior Insys wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Indivior Insys must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.